Financial Ratios Huvitz Co., Ltd.
Equities
A065510
KR7065510000
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,010.00 KRW | +0.75% |
|
+3.35% | -1.60% |
2024 | Huvitz Co., Ltd.(KOSDAQ:A065510) dropped from S&P Global BMI Index | CI |
2023 | Huvitz Co., Ltd.(KOSDAQ:A065510) added to S&P Global BMI Index | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.79 | 3.91 | 7.14 | 5.41 | 3.94 | |||||
Return on Total Capital | 3.17 | 4.51 | 8.27 | 6.28 | 4.61 | |||||
Return On Equity % | -3.38 | 10.13 | 16.27 | 10.04 | 7.02 | |||||
Return on Common Equity | -3.27 | 10.8 | 17.88 | 11 | 7.7 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.46 | 39.22 | 44.96 | 44.71 | 46.77 | |||||
SG&A Margin | 17.94 | 15.68 | 15.05 | 17.22 | 17.29 | |||||
EBITDA Margin % | 17.3 | 15.35 | 21.35 | 18.2 | 15.96 | |||||
EBITA Margin % | 12.42 | 11.66 | 17.99 | 14.74 | 12.06 | |||||
EBIT Margin % | 9.78 | 10.18 | 17.26 | 13.91 | 11.31 | |||||
Income From Continuing Operations Margin % | -4.32 | 9.58 | 15.2 | 9.64 | 7.1 | |||||
Net Income Margin % | -3.89 | 9.46 | 15.6 | 8.47 | 7.39 | |||||
Net Avail. For Common Margin % | -3.89 | 9.46 | 15.6 | 9.98 | 7.39 | |||||
Normalized Net Income Margin | 4.88 | 6.33 | 10.78 | 8.36 | 8.35 | |||||
Levered Free Cash Flow Margin | 10.15 | -1.56 | -9.14 | -9.49 | -17.33 | |||||
Unlevered Free Cash Flow Margin | 11.29 | -1.04 | -8.58 | -8.54 | -16.29 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.46 | 0.62 | 0.66 | 0.62 | 0.56 | |||||
Fixed Assets Turnover | 1.02 | 1.35 | 1.48 | 1.41 | 1.28 | |||||
Receivables Turnover (Average Receivables) | 3.73 | 6.51 | 6.53 | 5.85 | 4.29 | |||||
Inventory Turnover (Average Inventory) | 1.75 | 2.32 | 1.93 | 1.73 | 1.52 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.22 | 1.26 | 1.27 | 1.15 | 1.15 | |||||
Quick Ratio | 0.71 | 0.53 | 0.51 | 0.49 | 0.55 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.54 | 0.16 | 0.23 | 0.06 | |||||
Days Sales Outstanding (Average Receivables) | 98.2 | 56.04 | 55.94 | 62.38 | 85.4 | |||||
Days Outstanding Inventory (Average Inventory) | 208.82 | 157.28 | 189.54 | 211.13 | 240.67 | |||||
Average Days Payable Outstanding | 37.93 | 24.94 | 26.48 | 28.14 | 30.18 | |||||
Cash Conversion Cycle (Average Days) | 269.1 | 188.39 | 219 | 245.37 | 295.89 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 61.01 | 38.39 | 40.62 | 47.86 | 55.04 | |||||
Total Debt / Total Capital | 37.89 | 27.74 | 28.89 | 32.37 | 35.5 | |||||
LT Debt/Equity | 9.21 | 3.46 | 1.07 | 0.69 | 0.29 | |||||
Long-Term Debt / Total Capital | 5.72 | 2.5 | 0.76 | 0.47 | 0.19 | |||||
Total Liabilities / Total Assets | 45.53 | 38.07 | 38.24 | 42.03 | 45.17 | |||||
EBIT / Interest Expense | 5.35 | 12.2 | 19.23 | 9.13 | 6.84 | |||||
EBITDA / Interest Expense | 9.46 | 18.39 | 23.78 | 11.94 | 9.65 | |||||
(EBITDA - Capex) / Interest Expense | 7.68 | 12.65 | 17.83 | 3.78 | 4.37 | |||||
Total Debt / EBITDA | 4.26 | 2.5 | 1.9 | 2.6 | 3.56 | |||||
Net Debt / EBITDA | 2.44 | 1.91 | 1.54 | 2.07 | 3.09 | |||||
Total Debt / (EBITDA - Capex) | 5.25 | 3.64 | 2.54 | 8.23 | 7.87 | |||||
Net Debt / (EBITDA - Capex) | 3.01 | 2.78 | 2.05 | 6.54 | 6.82 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -20.34 | 35.57 | 15.16 | 8.23 | 0.12 | |||||
Gross Profit, 1 Yr. Growth % | -17.69 | 25.23 | 32.03 | 5.72 | 4.73 | |||||
EBITDA, 1 Yr. Growth % | -30.34 | 20.29 | 60.16 | -12.45 | -12.18 | |||||
EBITA, 1 Yr. Growth % | -37.98 | 27.21 | 77.67 | -16.52 | -18.07 | |||||
EBIT, 1 Yr. Growth % | -41.49 | 41.12 | 95.28 | -18.07 | -18.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -136.33 | -400.65 | 82.69 | -36.01 | -26.3 | |||||
Net Income, 1 Yr. Growth % | -134.59 | -430.08 | 89.93 | -41.57 | -12.71 | |||||
Normalized Net Income, 1 Yr. Growth % | -45.69 | 75.61 | 96.23 | -21.15 | -0.03 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -136.48 | -437.85 | 89.86 | -36.27 | -26.79 | |||||
Accounts Receivable, 1 Yr. Growth % | -28.87 | 0.46 | 36.17 | 9.33 | 61.7 | |||||
Inventory, 1 Yr. Growth % | 0.86 | 15.38 | 34.58 | 9.89 | 9.28 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.18 | 0.91 | 8.99 | 15.84 | 6.06 | |||||
Total Assets, 1 Yr. Growth % | 2.35 | -1.34 | 15.53 | 13.51 | 10.43 | |||||
Tangible Book Value, 1 Yr. Growth % | -10.91 | 12.52 | 17.72 | 7.35 | 5.88 | |||||
Common Equity, 1 Yr. Growth % | -10.79 | 12.07 | 17.11 | 7.34 | 4.52 | |||||
Cash From Operations, 1 Yr. Growth % | -24.81 | 124.33 | -61.34 | 75.05 | -68.21 | |||||
Capital Expenditures, 1 Yr. Growth % | -57.1 | 99.44 | 28.51 | 150.29 | -29.7 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -4.89K | -120.85 | 574.04 | 20.06 | 82.82 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.4K | -112.48 | 850.2 | 15.63 | 91.1 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.73 | 3.92 | 24.95 | 11.31 | 4.1 | |||||
Gross Profit, 2 Yr. CAGR % | -1.07 | 1.53 | 28.59 | 18.85 | 5.22 | |||||
EBITDA, 2 Yr. CAGR % | -6.55 | -8.46 | 38.8 | 21.19 | -12.32 | |||||
EBITA, 2 Yr. CAGR % | -10.1 | -11.17 | 50.34 | 25.17 | -17.3 | |||||
EBIT, 2 Yr. CAGR % | -9.28 | -9.13 | 66.01 | 30.14 | -18.34 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -36.51 | 4.51 | 134.36 | 11.67 | -31.33 | |||||
Net Income, 2 Yr. CAGR % | -38.01 | 6.85 | 150.38 | 5.35 | -28.58 | |||||
Normalized Net Income, 2 Yr. CAGR % | -13.6 | -2.34 | 85.63 | 27.99 | -11.21 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -35.75 | 11.02 | 153.27 | 13.52 | -31.7 | |||||
Accounts Receivable, 2 Yr. CAGR % | -12.32 | -15.47 | 16.96 | 22.01 | 32.96 | |||||
Inventory, 2 Yr. CAGR % | 7.16 | 7.87 | 24.61 | 21.61 | 9.59 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.21 | 3.02 | 4.87 | 12.36 | 10.84 | |||||
Total Assets, 2 Yr. CAGR % | 4.76 | 0.49 | 6.76 | 14.51 | 11.96 | |||||
Tangible Book Value, 2 Yr. CAGR % | -3.11 | 0.12 | 15.09 | 12.42 | 6.61 | |||||
Common Equity, 2 Yr. CAGR % | -3.29 | -0.01 | 14.56 | 12.12 | 5.92 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.28 | 29.87 | -6.88 | -17.74 | -25.4 | |||||
Capital Expenditures, 2 Yr. CAGR % | 38.15 | -7.51 | 60.09 | 79.34 | 32.65 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 48.1 | 216 | 18.55 | 174.44 | 48.15 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 76 | 36.81 | 8.89 | 219.01 | 48.65 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.14 | 6.41 | 7.54 | 18.87 | 7.45 | |||||
Gross Profit, 3 Yr. CAGR % | 1.72 | 7.02 | 10.82 | 20.94 | 13.94 | |||||
EBITDA, 3 Yr. CAGR % | -4.68 | 1.66 | 10.3 | 20.89 | 8.85 | |||||
EBITA, 3 Yr. CAGR % | -7.27 | 0.93 | 11.92 | 25.85 | 8.68 | |||||
EBIT, 3 Yr. CAGR % | -9.05 | 5.12 | 17.26 | 33.7 | 11.29 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -12.45 | 6.62 | 25.89 | 55.35 | -2.78 | |||||
Net Income, 3 Yr. CAGR % | -4.32 | 8.24 | 29.43 | 54.15 | -1.05 | |||||
Normalized Net Income, 3 Yr. CAGR % | -4.16 | 9.45 | 23.23 | 42.22 | 17.87 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -11.2 | 11.73 | 32.76 | 63.29 | -1.92 | |||||
Accounts Receivable, 3 Yr. CAGR % | -5.6 | -8.25 | -0.91 | 14.36 | 34.02 | |||||
Inventory, 3 Yr. CAGR % | 10.24 | 9.83 | 16.13 | 19.5 | 17.35 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -0.08 | 3.76 | 4.97 | 8.4 | 10.22 | |||||
Total Assets, 3 Yr. CAGR % | 3.34 | 2.69 | 5.27 | 8.96 | 13.14 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.09 | 1.84 | 5.67 | 12.45 | 10.19 | |||||
Common Equity, 3 Yr. CAGR % | -0.09 | 1.58 | 5.4 | 12.1 | 9.53 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.89 | 39.73 | -13.29 | 14.93 | -40.08 | |||||
Capital Expenditures, 3 Yr. CAGR % | -47.63 | 56.14 | 3.21 | 85.81 | 31.25 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -8.15 | -22.96 | 306.77 | 16.24 | 139.68 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -3.07 | -27.16 | 161.02 | 8.29 | 168.92 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.12 | 7.26 | 9.22 | 8.35 | 6.02 | |||||
Gross Profit, 5 Yr. CAGR % | 1.12 | 5.02 | 11.72 | 11.6 | 8.8 | |||||
EBITDA, 5 Yr. CAGR % | -5.52 | -2.77 | 10.78 | 9.06 | 1.57 | |||||
EBITA, 5 Yr. CAGR % | -8.06 | -4.98 | 12.5 | 10 | 0.25 | |||||
EBIT, 5 Yr. CAGR % | -9.46 | -4.9 | 15.7 | 14.49 | 2.62 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -18.01 | -5.5 | 29.81 | 8.61 | 0.07 | |||||
Net Income, 5 Yr. CAGR % | -16.05 | -4.07 | 40.58 | 7.08 | 2.04 | |||||
Normalized Net Income, 5 Yr. CAGR % | -8.43 | -6.84 | 24.85 | 16.52 | 9.33 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -17.3 | -3.51 | 35.05 | 12.44 | 3.06 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.73 | -1.93 | 2.85 | 2.83 | 11.46 | |||||
Inventory, 5 Yr. CAGR % | 8.38 | 10.95 | 15.78 | 14.4 | 13.47 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.51 | -1.63 | 1.87 | 7.12 | 7.28 | |||||
Total Assets, 5 Yr. CAGR % | 6.3 | 1.91 | 4.7 | 7.26 | 7.9 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.92 | 2.99 | 5.84 | 5.95 | 6.05 | |||||
Common Equity, 5 Yr. CAGR % | 2.65 | 2.63 | 5.54 | 5.67 | 5.61 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.41 | 13.06 | -2.29 | 13.04 | -18.35 | |||||
Capital Expenditures, 5 Yr. CAGR % | -30.8 | -32.01 | -18.11 | 65.04 | 14.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.66 | -44.58 | 1.72 | 28.06 | 167.71 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.43 | -48.9 | 1.54 | 31.51 | 105.22 |
- Stock Market
- Equities
- A065510 Stock
- Financials Huvitz Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions